Cytokinetics Inc (CYTK)
Current ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 628,051 | 795,186 | 535,672 | 474,221 | 233,752 |
| Total current liabilities | US$ in thousands | 102,678 | 84,617 | 71,860 | 31,199 | 26,023 |
| Current ratio | 6.12 | 9.40 | 7.45 | 15.20 | 8.98 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $628,051K ÷ $102,678K
= 6.12
Cytokinetics Inc's current ratio has fluctuated over the past five years. As of December 31, 2023, the current ratio stands at 6.12, indicating that the company has $6.12 in current assets available for every $1 in current liabilities. This ratio has decreased from 9.40 in 2022, suggesting a potential weakening in the company's short-term liquidity position. Despite the decrease, the current ratio remains above 1, indicating that Cytokinetics Inc still has more than enough current assets to cover its current liabilities. However, a downward trend in the current ratio over multiple years may warrant further investigation into the company's management of working capital and liquidity.
Peer comparison
Dec 31, 2023